{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:23:17Z","timestamp":1793391797656,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,12,4]],"date-time":"2008-12-04T00:00:00Z","timestamp":1228348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s10067-008-1049-z","type":"journal-article","created":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T09:10:44Z","timestamp":1228295444000},"page":"327-331","source":"Crossref","is-referenced-by-count":69,"title":["Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes\u2014an Indian perspective"],"prefix":"10.1007","volume":"28","author":[{"given":"Rohit","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand N.","family":"Malaviya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,4]]},"reference":[{"issue":"Suppl 3","key":"1049_CR1","doi-asserted-by":"crossref","first-page":"iii3","DOI":"10.1136\/ard.61.suppl_3.iii3","volume":"61","author":"MA Khan","year":"2002","unstructured":"Khan MA (2002) Ankylosing spondylitis: introductory comments on its diagnosis and treatment. Ann Rheum Dis 61(Suppl 3):iii3\u2013iii7","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1049_CR2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10067-007-0727-6","volume":"27","author":"U Dincer","year":"2008","unstructured":"Dincer U, Cakar E, Kiralp MZ, Dursun H (2008) Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria. Clin Rheumatol 27(4):457\u2013462","journal-title":"Clin Rheumatol"},{"issue":"7","key":"1049_CR3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00296-007-0499-y","volume":"28","author":"E Feldtkeller","year":"2008","unstructured":"Feldtkeller E, Erlendsson J (2008) Definition of disease duration in ankylosing spondylitis. Rheumatol Int 28(7):693\u2013696","journal-title":"Rheumatol Int"},{"issue":"2","key":"1049_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61\u201366","journal-title":"Rheumatol Int"},{"issue":"3","key":"1049_CR5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/art.511","volume":"46","author":"F Bosch Van Den","year":"2002","unstructured":"Van Den Bosch F, Kruithof E, Baeten D, Herssens A, de Keyser F, Mielants H et al (2002) Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. Arthritis Rheum 46(3):755\u2013765","journal-title":"Arthritis Rheum"},{"issue":"18","key":"1049_CR6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","volume":"346","author":"JD Gorman","year":"2002","unstructured":"Gorman JD, Sack KE, Davis JC Jr (2002) Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 346(18):1349\u20131356","journal-title":"N Engl J Med"},{"issue":"6","key":"1049_CR7","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/art.11017","volume":"48","author":"J Brandt","year":"2003","unstructured":"Brandt J, Khariouzov A, Listing J, Haibel H, Sorensen H, Grassnickel L et al (2003) Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 48(6):1667\u20131675","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1049_CR8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.2003.016386","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J (2004) Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63(6):665\u2013670","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1049_CR9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM200102013440508","volume":"344","author":"RA Deyo","year":"2001","unstructured":"Deyo RA, Weinstein JN (2001) Low back pain. N Engl J Med 344(5):363\u2013370","journal-title":"N Engl J Med"},{"issue":"4","key":"1049_CR10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.32.4.354","volume":"32","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V (1973) New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis 32(4):354\u2013363","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1049_CR11","first-page":"1953","volume":"26","author":"J Oostveen","year":"1999","unstructured":"Oostveen J, Prevo R, den Boer J, van de Laar M (1999) Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J Rheumatol 26(9):1953\u20131958","journal-title":"J Rheumatol"},{"issue":"4","key":"1049_CR12","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.10883","volume":"48","author":"J Braun","year":"2003","unstructured":"Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J et al (2003) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 48(4):1126\u20131136","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1049_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1049_CR14","first-page":"945","volume":"26","author":"D Heijde van der","year":"1999","unstructured":"van der Heijde D, van der Linden S, Bellamy N, Calin A, Dougados M, Khan MA (1999) Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 26(4):945\u2013947","journal-title":"J Rheumatol"},{"issue":"12","key":"1049_CR15","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286\u20132291","journal-title":"J Rheumatol"},{"issue":"12","key":"1049_CR16","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281\u20132285","journal-title":"J Rheumatol"},{"issue":"8","key":"1049_CR17","first-page":"1609","volume":"22","author":"SD Jones","year":"1995","unstructured":"Jones SD, Porter J, Garrett SL, Kennedy LG, Whitelock H, Calin A (1995) A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI). J Rheumatol 22(8):1609","journal-title":"J Rheumatol"},{"issue":"9313","key":"1049_CR18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","volume":"359","author":"J Braun","year":"2002","unstructured":"Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W et al (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359(9313):1187\u20131193","journal-title":"Lancet"},{"key":"1049_CR19","unstructured":"Baraliakos X, Listing J, von der Recke A et al (2008) The long-term natural course of radiographic progression in ankylosing spondylitis\u2014evaluation of a large AS cohort Scand J Rheumatol 37(123s):33. [Abstract from the 32nd Scandinavian Congress of Rheumatology Jan 30\u2013Feb 3, 2008, held at Levi, Lapland, Finland]"},{"issue":"8","key":"1049_CR20","first-page":"1234","volume":"15","author":"A Calin","year":"1988","unstructured":"Calin A, Elswood J, Rigg S, Skevington SM (1988) Ankylosing spondylitis\u2014an analytical review of 1500 patients: the changing pattern of disease. J Rheumatol 15(8):1234\u20131238","journal-title":"J Rheumatol"},{"issue":"1","key":"1049_CR21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.0219-0494.2003.00028.x","volume":"6","author":"AN Malaviya","year":"2003","unstructured":"Malaviya AN (2003) The Feng Pao Hsii lecture: rheumatology in the Asia-Pacific region\u2014unmet needs and challenges. APLAR J Rheumatol 6(1):68\u201376","journal-title":"APLAR J Rheumatol"},{"issue":"2","key":"1049_CR22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.21619","volume":"54","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Metter A, Listing J, Sieper J, Braun J (2006) Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54(2):569\u2013578","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-1049-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-008-1049-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-1049-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:32Z","timestamp":1559119892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-008-1049-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,4]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["1049"],"URL":"https:\/\/doi.org\/10.1007\/s10067-008-1049-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,4]]}}}